Michael has extensive experience investing in and working with healthcare companies from payors, to providers, technology solutions, and other ancillary services. In addition, Michael has served on the board of companies ranging from $50 million to over $3 billion in enterprise value.
Prior to founding Stellar Health, Michael was a Principal in the Healthcare Group at Apax Partners, a large cap global private equity firm. Key deals that he led and worked
on include Vyaire Medical (medical technology), Ideal Protein (consumer health), Medicomp (medical technology), One Call Care Management (workers’ comp network services, identifying best in class providers; previously named One Call Medical), GENEX (workers’ comp nurse case management) Qualitest Pharmaceuticals (generic pharmaceuticals), and TriZetto (payor and provider IT).
Previous to his tenure at Apax Partners, Michael was a member of Lazard’s Healthcare Mergers & Acquisitions Group in New York, where he worked on pharma, biotech, and healthcare services M&A and financing transactions. He received his MBA in Healthcare Management from The Wharton School of Business and his Bachelor’s of Business Administration degree from the Ross School of Business at the University of Michigan.